FNY Investment Advisers’s Akcea Therapeutics Inc AKCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5
Closed 1020
2020
Q3
$0 Buy
+5
New +$71 ﹤0.01% 679

FNY Investment Advisers's AKCA Position: Q4 2020 in Review

FNY Investment Advisers sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 5 shares.

FNY Investment Advisers first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • FNY Investment Advisers reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 5 Akcea Therapeutics Inc shares in Q4 2020.
  • FNY Investment Advisers first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
  • FNY Investment Advisers's Akcea Therapeutics Inc position peaked at $0 in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on FNY Investment Advisers's 13F filing for Q4 2020, filed 19 Jan 2021.